Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Lannett Company, Inc.    LCI

News SummaryMost relevantAll newsSector newsTweets

Lannett : Appoints Samuel H. Israel As General Counsel

share with twitter share with LinkedIn share with facebook
share via e-mail
07/17/2017 | 12:54pm CEST

PHILADELPHIA, July 17, 2017 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the appointment of Samuel H. Israel as vice president, chief legal officer and general counsel.

"I am very pleased to welcome Sam to the Lannett senior management team," said Arthur Bedrosian, chief executive officer of Lannett. "Sam is an exceptional attorney, with more than 20 years of strategic and legal experience representing life sciences and healthcare companies. For the last 19 years, he served as Lannett's outside general counsel, coordinating all aspects of the company's legal work and helping to guide its growth, which will allow him to hit the ground running. Sam strengthens our team, as well as our ability to expand our business both domestically and globally."

Prior to joining Lannett, Israel, 55, was a partner with Fox Rothschild, a national, full-service law firm, with 22 offices that provide services in more than 60 practice areas. He served as chair of the firm's Pharmaceutical and Biotechnology Practice and handled a variety of commercial litigation matters. Israel earned a bachelor of science degree in chemical engineering from the University of Pennsylvania and a juris doctor degree with honors from Rutgers University School of Law. He lives in Philadelphia with his wife and daughter.

About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company's website at www.lannett.com.

Contact: Robert Jaffe
Robert Jaffe Co., LLC
(424) 288-4098

View original content with multimedia:http://www.prnewswire.com/news-releases/lannett-appoints-samuel-h-israel-as-general-counsel-300488843.html

SOURCE Lannett Company, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on LANNETT COMPANY, INC.
10/18 LANNETT : Generic Drugs Stocks on Investors' Radar -- pSivida, Tetraphase Pharma..
10/05 LANNETT : Board Of Directors Initiates CEO Search
10/05 LANNETT : Announces Dismissal Of Class Action Lawsuit
10/04 LANNETT : Receives Two FDA Approvals For Lansoprazole Delayed-Release Capsules U..
10/02 LANNETT : Receives Two FDA Approvals For Lansoprazole Delayed-Release Capsules U..
09/29 LANNETT COMPANY, INC. : Corporate News Blog - Lannett Gets FDA Approval for Oxyc..
09/29 LANNETT : Receives FDA Approval for Oxycodone and Acetaminophen Tablets USP, 5 m..
09/28 LANNETT : Arthur Bedrosian, Lannett CEO, Prevails In Lawsuit With Internal Reven..
09/28 LANNETT : Receives Approval for Dexmethylphenidate Hydrochloride Tablets, 2.5 mg..
09/28 LANNETT : Announces Dismissal 0f Class Action Lawsuit
More news
News from SeekingAlpha
10/02 FDA OKs Lannett's generic Prevacid; shares ahead 8%
09/28 Short Interest Report - The Most Heavily Shorted Stocks
09/27 Lannett receives FDA approval for Oxycodone and Acetaminophen tablets USP, 5 ..
09/26 FDA OKs Lannett's generic Focalin; shares up 1%
09/25 Lannett launches CEO search; shares slip 4% premarket